Table 4.

Reasons for chemotherapy delays.

Reasons for chemotherapy delays	Arm 1	Arm 2
	FOLFOX + Bevacizumab	FOLFOXIRI + Bevacizumab
	N = 10	N = 10
Administrative reason/error	3 (30%)	4 (40%)
Patient choice	-	3 (30%)
Neutropenia	3 (30%)	6 (60%)
Febrile neutropenia	-	1 (10%)
Respiratory tract infection	-	1 (10%)
Thrombocytopenia	2 (20%)	-
Other adverse event	1 (10%)	-
Any adverse event related reason	4 (40%)	6 (60%)
Any reason	6 (60%)	8 (80%)